210 related articles for article (PubMed ID: 32341465)
1. Diabetes downregulates peptide transporter 1 in the rat jejunum: possible involvement of cholate-induced FXR activation.
Liang LM; Zhou JJ; Xu F; Liu PH; Qin L; Liu L; Liu XD
Acta Pharmacol Sin; 2020 Nov; 41(11):1465-1475. PubMed ID: 32341465
[TBL] [Abstract][Full Text] [Related]
2. Impairment of Intestinal Monocarboxylate Transporter 6 Function and Expression in Diabetic Rats Induced by Combination of High-Fat Diet and Low Dose of Streptozocin: Involvement of Butyrate-Peroxisome Proliferator-Activated Receptor-
Xu F; Zhu L; Qian C; Zhou J; Geng D; Li P; Xuan W; Wu F; Zhao K; Kong W; Qin Y; Liang L; Liu L; Liu X
Drug Metab Dispos; 2019 Jun; 47(6):556-566. PubMed ID: 30923035
[TBL] [Abstract][Full Text] [Related]
3. Irinotecan-induced gastrointestinal damage alters the expression of peptide transporter 1 and absorption of cephalexin in rats.
Imaoka A; Hattori T; Akiyoshi T; Ohtani H
Biopharm Drug Dispos; 2023 Oct; 44(5):372-379. PubMed ID: 37507848
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
5. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
[TBL] [Abstract][Full Text] [Related]
6. Intestinal absorption of cephalexin in diabetes mellitus model rats.
Watanabe K; Terada K; Sato J
Eur J Pharm Sci; 2003 Jun; 19(2-3):91-8. PubMed ID: 12791410
[TBL] [Abstract][Full Text] [Related]
7. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
Hu X; Bonde Y; Eggertsen G; Rudling M
J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
Zhang HM; Wang X; Wu ZH; Liu HL; Chen W; Zhang ZZ; Chen D; Zeng TS
Mol Med Rep; 2016 Mar; 13(3):2135-42. PubMed ID: 26782298
[TBL] [Abstract][Full Text] [Related]
9. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
[TBL] [Abstract][Full Text] [Related]
10. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
11. PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.
Buyse M; Berlioz F; Guilmeau S; Tsocas A; Voisin T; Péranzi G; Merlin D; Laburthe M; Lewin MJ; Rozé C; Bado A
J Clin Invest; 2001 Nov; 108(10):1483-94. PubMed ID: 11714740
[TBL] [Abstract][Full Text] [Related]
12. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
13. Effects of progesterone and norethisterone on cephalexin transport and peptide transporter PEPT1 expression in human intestinal cell line Caco-2.
Watanabe K; Jinriki T; Sato J
Biol Pharm Bull; 2006 Jan; 29(1):90-5. PubMed ID: 16394517
[TBL] [Abstract][Full Text] [Related]
14. Meat proteins had different effects on oligopeptide transporter PEPT1 in the small intestine of young rats.
Li M; Li C; Song S; Zhao F; Xu X; Zhou G
Int J Food Sci Nutr; 2016 Dec; 67(8):995-1004. PubMed ID: 27455889
[TBL] [Abstract][Full Text] [Related]
15. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.
Yang B; Smith DE
Drug Metab Dispos; 2013 Mar; 41(3):608-14. PubMed ID: 23264448
[TBL] [Abstract][Full Text] [Related]
16. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
[TBL] [Abstract][Full Text] [Related]
17. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway.
Song M; Ye J; Zhang F; Su H; Yang X; He H; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
J Agric Food Chem; 2019 Aug; 67(32):8868-8874. PubMed ID: 31319027
[TBL] [Abstract][Full Text] [Related]
18. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
19. Chenodeoxycholic Acid Releases Proinflammatory Cytokines from Small Intestinal Epithelial Cells Through the Farnesoid X Receptor.
Horikawa T; Oshima T; Li M; Kitayama Y; Eda H; Nakamura K; Tamura A; Ogawa T; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Tomita T; Fukui H; Watari J; Miwa H
Digestion; 2019; 100(4):286-294. PubMed ID: 30844798
[TBL] [Abstract][Full Text] [Related]
20. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
